AN2 Therapeutics, Inc. (ANTX)
3.55
-0.09
(-2.47%)
USD |
NASDAQ |
Oct 23, 16:00
3.555
0.00 (0.00%)
After-Hours: 20:00
AN2 Therapeutics Price : 3.55 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 3.61 | 3.660 | 3.47 | 3.55 | 124440.0 |
| Oct 22, 2026 | 3.57 | 3.72 | 3.521 | 3.64 | 95191.00 |
| Oct 21, 2026 | 3.58 | 3.78 | 3.57 | 3.60 | 177367.0 |
| Oct 20, 2026 | 3.38 | 3.59 | 3.36 | 3.56 | 129744.0 |
| Oct 19, 2026 | 3.39 | 3.46 | 3.21 | 3.37 | 330871.0 |
| Oct 16, 2026 | 3.60 | 3.62 | 3.30 | 3.38 | 281730.0 |
| Oct 15, 2026 | 3.50 | 3.69 | 3.50 | 3.60 | 295943.0 |
| Oct 14, 2026 | 3.55 | 3.73 | 3.33 | 3.54 | 431026.0 |
| Oct 13, 2026 | 4.30 | 4.32 | 3.59 | 3.60 | 515051.0 |
| Oct 12, 2026 | 4.41 | 4.41 | 4.24 | 4.30 | 298465.0 |
| Oct 09, 2026 | 4.65 | 4.67 | 4.26 | 4.40 | 442134.0 |
| Oct 08, 2026 | 4.77 | 4.86 | 4.43 | 4.68 | 427826.0 |
| Oct 07, 2026 | 5.02 | 5.06 | 4.695 | 4.85 | 365253.0 |
| Oct 06, 2026 | 5.39 | 5.60 | 5.005 | 5.07 | 318215.0 |
| Oct 05, 2026 | 5.69 | 5.86 | 5.50 | 5.61 | 299950.0 |
| Oct 02, 2026 | 5.64 | 5.99 | 5.51 | 5.71 | 451334.0 |
| Oct 01, 2026 | 5.29 | 5.73 | 5.155 | 5.62 | 509440.0 |
| Sep 30, 2026 | 5.07 | 5.35 | 5.00 | 5.32 | 199205.0 |
| Sep 29, 2026 | 4.99 | 5.20 | 4.76 | 5.09 | 178839.0 |
| Sep 28, 2026 | 4.89 | 5.17 | 4.670 | 5.01 | 318456.0 |
| Sep 25, 2026 | 4.91 | 4.95 | 4.71 | 4.88 | 155127.0 |
| Sep 24, 2026 | 4.77 | 5.06 | 4.72 | 4.89 | 258937.0 |
| Sep 23, 2026 | 4.86 | 4.95 | 4.67 | 4.83 | 306158.0 |
| Sep 22, 2026 | 5.00 | 5.05 | 4.70 | 4.83 | 191681.0 |
| Sep 21, 2026 | 5.06 | 5.25 | 4.92 | 4.96 | 305221.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Cocrystal Pharma, Inc. | 0.95 |
| CNBX Pharmaceuticals, Inc. | 0.0001 |
| Arvinas, Inc. | 7.30 |
| Fulcrum Therapeutics, Inc. | 3.68 |
| Definium Therapeutics, Inc. | 35.67 |
Price Related Metrics
| Price to Book Value | 1.698 |
| Earnings Yield | -30.23% |
| Market Cap | 128.90M |